Home News Page 51

Nick Fuentes suggests ICE killing Renee Good is “probably a good thing” because the “future is at stake, whether white people exist as a race”

Nick Fuentes suggests ICE killing Renee Good is “probably a good thing” because the “future is at stake, whether white people exist as a race”

NICK FUENTES (HOST): Our featured story, we’re talking all about Renee Good, the 37-year-old activist who was shot and killed by ICE last week, tragically.

I have to tell you, it is really striking that there was apparently a divide about this on the far right. And it seems that the more race-conscious, immigration-restrictionist, far-right people knew that this is not a tragedy, this is probably a good thing. And then it seems that the Israel critical, Jewish critical elements on the far right, for whatever reason, said this is a horrible tragedy and they’re coming out against ICE. And I saw some ridiculous cope about this. I saw some people say that ICE is trained by the Israeli Defense Forces, so this is Trump siccing the IDF on white people, on white women. Wow, that’s a stretch. That’s a new one. And I’m really shocked by that, but it’s a little bit alarming.

Nobody on our side should be mourning this person. Once you know who she is and what she’s about and everything, and yes, actually all of that matters. I see a lot of people hand-waving that away and saying, “It doesn’t matter what side she’s on. She’s a human being.” Don’t get me wrong, I wish we lived in a world where nobody was dying and nobody had to die and we weren’t engaged in this conflict. But the fact of the matter is, as we all know, we are.

We do live in a world where we are engaged in a political struggle. We are engaged in a war actually, and the stakes could not be higher. This is about our civilization. This is about our ancestors, about our posterity. Their future is at stake, whether white people exist as a race. And everything that that entails, Christendom, Western civilization, all of it, it’s all at stake. And of course we have people in the country that are fighting to prevent this from happening, fighting to prevent us from preserving these things all the time.

And so, it absolutely matters what side of this issue you’re on. We’re being invaded. The people come here. They take advantage. They loot and pillage. They get caught red-handed, in this case in Minneapolis, this Somalian enclave, they get caught with their hand in the cookie jar, stealing perhaps billions of dollars of federal assistance and other money. And some people, it’s their first instinct to jump in and defend those people literally at the peril of their own life. I say, if that’s a game you want to play, good riddance.

Great Job Media Matters for America & the Team @ Media Matters for America Source link for sharing this story.

TPR News Now: Friday, January 16, 2026

TPR News Now: Friday, January 16, 2026

Listen to TPR’s morning newscast for a roundup of the latest headlines and news developments.

This morning’s headlines:

  • Uvalde trial resumes today following a brief pause on Thursday
  • SA city council OKs approved federal building purchase for Project Marvel
  • Upgrades to Brackenridge Park continue following lawsuit
  • Veterans show out for local job fair
  • How new eviction laws impact Bexar County residents

Today’s weather in San Antonio: Sunny with a high near 72 and some strong winds. Mostly clear tonight with a low near 43.

Great Job Marian Navarro & the Team @ Texas Public Radio for sharing this story.

Weight Loss Pills: How They Work, Safety, and History

Weight Loss Pills: How They Work, Safety, and History

For many patients today, a decision about which weight loss medication to try may come down to several factors, including what other medications they take, which drugs are covered by insurance or are most affordable, and whether people prefer pills or injected medicines, Dr. Jay says.

“I advise people to speak to their physician to choose an initial medication and see how they respond,” Jay says. “It’s not uncommon to switch medications or have to add a second or third medication.”

Here’s what you need to know about the prescription weight loss drugs that are currently approved.

Tirzepatide (Zepbound)

This weekly injected medicine was approved by the FDA in 2023 to treat adults with obesity and overweight adults with at least one weight-related chronic health problem.

How it works: Tirzepatide mimics two hormones that regulate insulin secretion and digestion: glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is widely believed to be the most potent weight loss drug ever approved for sale: In the SURMOUNT-1 trial, participants using the highest dose lost an average of 22.5 percent of their body weight.

Common side effects: Nausea, diarrhea, vomiting, and constipation.

Interactions and risks: Rare but potentially dangerous reactions include severe gastrointestinal disease and acute injury to the pancreas, kidneys, or gallbladder.

Semaglutide (Wegovy)

Wegovy was approved by the FDA to treat adults with obesity as well as adults who are overweight and also have at least one weight-related chronic health problem. The weekly injected form of the medicine was approved in 2021, and the once-daily oral version was approved in 2025.

How it works: It’s another GLP-1 receptor agonist that mimics a hormone in the brain that regulates appetite.

Common side effects: Nausea, diarrhea, vomiting, constipation, stomach pain, headache, and fatigue.

Interactions and risks: It can’t be used in combination with liraglutide or other GLP-1 receptor agonists that are prescribed for type 2 diabetes. Like other drugs in this family of medicines, including tirzepatide and liraglutide, it carries an increased risk of pancreatitis and has been linked to thyroid tumors in animals.

Naltrexone-Bupropion (Contrave)

This oral drug was approved by the FDA in 2014.

How it works: It’s a combination of two drugs that are used to treat addiction and depression, and it suppresses appetite and makes people feel full sooner.

Common side effects: Constipation, dizziness, diarrhea, dry mouth, headache, increased blood pressure, elevated heart rate, insomnia, liver damage, nausea, and vomiting.

Interactions and risks: It shouldn’t be used by people with uncontrolled blood pressure, seizures, a history of anorexia or bulimia, people taking psychiatric drugs containing bupropion (Wellbutrin, Zyban), or individuals dependent on opioids or in withdrawal from drugs or alcohol. It can increase suicidal thoughts or actions.

Liraglutide (Saxenda)

This daily injected drug was approved by the FDA in 2014 for adults and in 2020 for children ages 12 and older with obesity.

How it works: It’s in a family of medicines known as glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking a hormone in the brain that regulates appetite and food consumption.

Common side effects: Nausea, diarrhea, constipation, abdominal pain, headache, and increased heart rate. Rare side effects include an increased risk of pancreatitis, and it’s been linked to thyroid tumors in animals.

Interactions and risks: In a smaller dose, liraglutide is used as a diabetes medication called Victoza, which should not be used in conjunction with Saxenda.

Phentermine-Topiramate (Qsymia)

This pill was approved by the FDA in 2012 for adults who are overweight or obese, and in 2022 for patients ages 12 and older with obesity.

How it works: This combination pill suppresses appetite and makes people feel full sooner.

Common side effects: Constipation, dizziness, dry mouth, tingling in hands and feet, brain fog or cognitive impairment, and difficulty sleeping.

Interactions and risks: It shouldn’t be used by people with glaucoma or hyperthyroidism, by women who are pregnant or breastfeeding, or by some individuals with a history of heart attack, stroke, heart rhythm disorders, kidney disease, or mood problems.

Orlistat (Xenical, Alli)

This pill was approved by the FDA in 1999 as a prescription weight loss drug (Xenical) and in 2007 at a lower dose for nonprescription use (Alli).

How it works: It works in the gut to limit the amount of fat absorbed from foods you eat.

Common side effects: Diarrhea, gas, stomach pain, and oily stool leakage.

Interactions and risks: It’s linked to rare cases of severe liver injury; dangerous interactions with cyclosporine, a drug to prevent organ transplant rejections; and the potential for malnutrition if patients don’t take a multivitamin.

 Orlistat has been shown to decrease the absorption of fat-soluble vitamins as well as some prescription medications, including Amiodarone (used to treat irregular heartbeats)and ciclosporin (used to treat inflammatory diseases like rheumatoid arthritis). Orlistat may also affect the dosage of warfarin, an anticoagulant.

Great Job Lisa Rapaport & the Team @ google-discover Source link for sharing this story.

X is down for the second time this week | TechCrunch

X is down for the second time this week | TechCrunch

Elon Musk’s X is experiencing its second large-scale outage this week.

The site and app, formerly known as Twitter, are either not loading at all or glitching into life briefly before throwing up error messages like gang signs.

The site Down Detector shows nearly 80,000 reports of X being down starting at around 10am eastern time, and is still down at the time of this writing.

This is the second major outage at X this week, following an earlier technical issue. It comes as the platform faces criticism after Grok, xAI’s chatbot that is integrated into X, has been fulfilling user requests to manipulate real photos of women, and even children, into nonconsensual sexual and violent imagery.

When Musk took over Twitter in 2022, he laid off much of the staff, sparking worries that the site wouldn’t be able to function normally or adequately monitor for harmful content. The site has largely remained running, though there were notable outages last year.

Image Credits:TechCrunch

TechCrunch has reached out to X for comment.

Great Job Rebecca Bellan & the Team @ TechCrunch Source link for sharing this story.

Frigidaire expands recall of minifridges sold at Target over fire hazard

Frigidaire expands recall of minifridges sold at Target over fire hazard

An appliance distributor is expanding a recall Frigidaire-branded minifridges sold in the U.S. after multiple fire reports.

Canada-based Curtis International initially recalled about 634,000 minifridges last year and has now added another 330,000 units of another six-can model, according to a notice published U.S. Consumer Product Safety Commission.

The recalled fridges have electrical components that can short circuit and ignite the plastic used to make the product — risking fires and potential burns for users. The company has received six reports of fires resulting in property damage linked to these products, according to the CPSC.

The 330,000 Frigidaire minifridges now under recall carry the model number EFMIS121 and were sold exclusively at Target, both in-stores and online, for about $30. Curtis International says the recalled fridges were made between January 2020 and December 2023.

The 634,000 minifridges recalled last year had model numbers EFMIS129, EFMIS137, EFMIS149 and EFMIS175 and were sold by retailers like Walmart and Amazon for between $36 and $40, per the CPSC. Another 26 incidents that included the products overheating, melting or catching fire were reported at the time, as well as two related smoke inhalation injuries.

Owners of the recalled minifridges are urged to stop using them immediately and visit Curtis International’s website to learn how to request a refund. Eligible consumers will need cut their product’s power cord, write “recall” in permanent marker on the fridge’s front door and send photos to the company.

Curtis International has licenses to make and distribute a range of consumer electronics and appliances — including some Frigidaire products. But the larger Frigidaire brand is owned by the Electrolux Group, a Swedish company.

Great Job NBC Staff and AP & the Team @ NBC 5 Dallas-Fort Worth for sharing this story.

NYC nonprofit trains people for energy efficiency jobs and does so much more » Yale Climate Connections

NYC nonprofit trains people for energy efficiency jobs and does so much more » Yale Climate Connections

Transcript:

A program in New York City is helping train people for jobs in energy efficiency – and changing their lives.

Smith: “It gives people hope. And it gives people opportunity that they might not feel like they had.”

Munir Smith graduated from the nonprofit Stacks and Joules’ building automation training program. It’s run in partnership with Henry Street Settlement, a social service agency on Manhattan’s Lower East Side.

Trainees learn how to install and operate technology that automates a building’s lights and HVAC equipment, which can save a lot of energy.

Michael Conway, cofounder of Stacks and Joules, says the program goes beyond teaching skills. It also provides comprehensive support to students, some of whom struggle with poverty or homelessness.

Conway: “If housing comes up, there’s access to support there. If there’s food or nutritional requirements, if there’s transportation, if they need eyeglasses, if they need, you know, clothes that are appropriate for interviews.”

So by helping trainees overcome barriers, the program provides a path to well-paying careers in energy efficiency.

Smith: “And so, you know, I’m always looking at my classmates achieve great things. … So it’s a proud fraternity to be in.”

Reporting credit: Sarah Kennedy / ChavoBart Digital Media

Great Job YCC Team & the Team @ Yale Climate Connections Source link for sharing this story.

Keeping Score: Renee Good Fatally Shot by ICE; Women Work Longer and Are Paid Less Worldwide; N.Y. Fights Back Against Federal Childcare Freeze

Keeping Score: Renee Good Fatally Shot by ICE; Women Work Longer and Are Paid Less Worldwide; N.Y. Fights Back Against Federal Childcare Freeze

In every issue of Ms., we track research on our progress in the fight for equality, catalogue can’t-miss quotes from feminist voices and keep tabs on the feminist movement’s many milestones. We’re Keeping Score online, too—in this biweekly roundup.

Lest We Forget

“We had whistles. They had guns.”

—Becca Good, wife of Renee Good, who was shot and killed by ICE agent Jonathan Ross in Minneapolis. Renee was an American mother of three, whose murder sparked protests against ICE in Minneapolis and cities across the country. 

 A person holds a sign reading "Good Rest in Power"
A vigil on Jan. 14, 2026, at a memorial near the site where Renee Good was killed in Minneapolis. Good was fatally shot by an immigration enforcement agent during an incident in south Minneapolis on Jan. 7. (Stephen Maturen / Getty Images)

“If you have ever received healthcare in America, you have been cared for by a nurse. A federal proposal under review excludes graduate nursing education from consideration as a professional degree and therefore excludes nurses from some federal graduate student loan programs. Over time, this could impact both patient safety and access to healthcare services. A strong nursing workforce is critical to high-quality patient care.”

—Virginia Nurses Association president Dr. Kathy Baker, PhD, RN, NE-BC, FAAN. The Trump administration plans to remove graduate-level nursing programs from their list of “professional degrees,” which will greatly restrict the amount of federal student loan support available.

“In one night, the Sandy Creek flood wiped out everything my family had built over 36 years—three homes, our business, and our sense of safety. We lost neighbors, were stranded for days without help, and watched as FEMA response was delayed while families were left to survive on their own.

More than five months later, many are still homeless, and only 36 percent of FEMA claims in our area have been approved. Disasters don’t care about politics, and emergency response shouldn’t either. FEMA must be independent, fully funded and strengthened—because when it fails to function, real families pay the price.”

— Brandy Gerstner, survivor of the Sandy Creek flooding in Texas. More than 80 disaster survivors shared their stories at the U.S. Capitol and warned of systemic failures under Homeland Security Secretary Kristi Noem

Disaster survivors in front of the U.S. Capitol.

“To my brown sisters and little brown girls watching tonight: Our softness is not a liability. Our depth is not too much. Our light does not need permission to shine. We belong in every room we walk into. Our voices matter, and our dreams deserve space.”

—Actor, singer and songwriter Teyana Taylor at the Golden Globes sent a powerful message after winning the award for Best Supporting Female Actor in a Motion Picture.